azacitidine oral,Romidepsin,Belinostat,Gemcitabine
bms,Aurobindo,Spectrum Pharma
['ptcl', 'aza ', 'oral aza', 'lymsm', 'cml']
shift in the chop-plus paradigm in ptcl with this phase 2 study of oral aza + romi, with orr 70% (cr 50%) in the upfront (!!!) setting. ongoing phase 3 study underway. #17icml #lymsm 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈